<DOC>
	<DOCNO>NCT02217813</DOCNO>
	<brief_summary>Each subject give tafamidis . After swallow single tafamidis capsule , tafamidis blood concentration measure periodically one week . After 20 day , subject take different form tafamidis capsule process repeat . Tafamidis concentration two different formulation compare determine approximately .</brief_summary>
	<brief_title>A Bioequivalence Study Comparing Two Different Tafamidis Formulations</brief_title>
	<detailed_description />
	<criteria>Healthy male female nonchild bear potential . Body Mass Index ( BMI ) 17.5 30.5 Kg total body weight 50 Kg ( 110 lb ) . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . Use prescription nonprescription drug dietary supplement within 7 day 5 half life ( whichever longer ) prior first dose study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>